You don’t make money when you buy stocks. And you don’t make money when you sell stocks. You make money by waiting. - The Dhando Investor (Mohnish Pabrai)
As you probably know, I'm mostly focused on small- and mid-cap ("SMID") bioscience equities. And my "sweet spots" are growth companies having approximately $1B market cap. I strongly believe that there's substantially more room for growth for companies around that size. Concurrently, there's adequate capitalization to raise cash without significantly diluting the stock's value. Nonetheless, there are exceptions to all rules. Accordingly, Sesen Bio (SESN)